Cannabix (TSE:BLO) has released an update.
Cannabix Technologies Inc. has successfully implemented its Breath Logix Alcohol Device at the Friedel Clinic in Montana, revolutionizing the clinic’s 24/7 Sobriety Program by enabling efficient and autonomous alcohol testing. The device, which performs breath analysis and identity confirmation through photo capture, has been praised for saving time and money while integrating seamlessly into the clinic’s daily operations. Cannabix’s innovation offers a promising tool for law enforcement and employers to promote public safety.
For further insights into TSE:BLO stock, check out TipRanks’ Stock Analysis page.
